E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma

Jaswinder Singh, Dinesh Kumar Pasi, Manju Bala, Ashwani Kumar, Amarjit Singh, Ruchi Jakhar, Akanksha Sharma, Anshu Saini.

Abstract
Background: The importance of prostatic carcinoma and its detection has increased manifold over the last few decades. Total serum acid phosphatase (ACP) was the world’s first emerged clinically useful tumor marker in the 1940s and 1950s in patients with prostatic diseases. With the introduction of the prostatic specific antigen (PSA) test in the 1980s, which performed significantly better in screening and treatment programs bringing disfavor to the advent of ACP.

Aims and Objectives: To determine serum PSA and total serum ACP in patients with prostatic cancer and benign prostatic diseases, followed by evaluation of these tumor markers.

Materials and Methods: This study was conducted on 30 patients with histologically proven cases of prostatic carcinoma and compared against 30 patients as control with benign prostatic pathology, residing in Punjab who were admitted and treated with symptoms complex of prostatism or retention urine or other urinary complaints as the primary symptoms. PSA and ACP in serum were determined using ELISA test kit and King and Kind method, respectively.

Results: The mean level of serum PSA was 81.19 ± 49.02 for cancer prostate and 4.975 for benign prostatic diseases, while the mean level of serum ACP was 5.22 ± 1.70 and 2.52 ± 2.27, respectively, for the cancer prostate and benign prostatic diseases showing statistically difference between study and control groups was highly significant as P < 0.0001.

Conclusion: Statistical analysis and results of the present study indicated that although serum ACP has better specificity to PSA, yet later is a very sensitive tumor marker in prostate diseases for screening, diagnosis, and post-treatment follow-up.

Key words: Serum Prostatic-Specific Antigen; Total Serum Acid Phosphatase; Prostate Carcinoma; Benign Prostatic Diseases and Punjab State


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Jaswinder Singh
Articles by Dinesh Kumar Pasi
Articles by Manju Bala
Articles by Ashwani Kumar
Articles by Amarjit Singh
Articles by Ruchi Jakhar
Articles by Akanksha Sharma
Articles by Anshu Saini
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Singh J, Pasi DK, Bala M, Kumar A, Singh A, Jakhar R, Sharma A, Saini A. Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma. Natl J Physiol Pharm Pharmacol. 2023; 13(5): 1065-1071. doi:10.5455/njppp.2023.13.03140202304042023


Web Style

Singh J, Pasi DK, Bala M, Kumar A, Singh A, Jakhar R, Sharma A, Saini A. Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma. https://www.njppp.com/?mno=146824 [Access: January 31, 2024]. doi:10.5455/njppp.2023.13.03140202304042023


AMA (American Medical Association) Style

Singh J, Pasi DK, Bala M, Kumar A, Singh A, Jakhar R, Sharma A, Saini A. Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma. Natl J Physiol Pharm Pharmacol. 2023; 13(5): 1065-1071. doi:10.5455/njppp.2023.13.03140202304042023



Vancouver/ICMJE Style

Singh J, Pasi DK, Bala M, Kumar A, Singh A, Jakhar R, Sharma A, Saini A. Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma. Natl J Physiol Pharm Pharmacol. (2023), [cited January 31, 2024]; 13(5): 1065-1071. doi:10.5455/njppp.2023.13.03140202304042023



Harvard Style

Singh, J., Pasi, . D. K., Bala, . M., Kumar, . A., Singh, . A., Jakhar, . R., Sharma, . A. & Saini, . A. (2023) Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma. Natl J Physiol Pharm Pharmacol, 13 (5), 1065-1071. doi:10.5455/njppp.2023.13.03140202304042023



Turabian Style

Singh, Jaswinder, Dinesh Kumar Pasi, Manju Bala, Ashwani Kumar, Amarjit Singh, Ruchi Jakhar, Akanksha Sharma, and Anshu Saini. 2023. Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma. National Journal of Physiology, Pharmacy and Pharmacology, 13 (5), 1065-1071. doi:10.5455/njppp.2023.13.03140202304042023



Chicago Style

Singh, Jaswinder, Dinesh Kumar Pasi, Manju Bala, Ashwani Kumar, Amarjit Singh, Ruchi Jakhar, Akanksha Sharma, and Anshu Saini. "Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 1065-1071. doi:10.5455/njppp.2023.13.03140202304042023



MLA (The Modern Language Association) Style

Singh, Jaswinder, Dinesh Kumar Pasi, Manju Bala, Ashwani Kumar, Amarjit Singh, Ruchi Jakhar, Akanksha Sharma, and Anshu Saini. "Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma." National Journal of Physiology, Pharmacy and Pharmacology 13.5 (2023), 1065-1071. Print. doi:10.5455/njppp.2023.13.03140202304042023



APA (American Psychological Association) Style

Singh, J., Pasi, . D. K., Bala, . M., Kumar, . A., Singh, . A., Jakhar, . R., Sharma, . A. & Saini, . A. (2023) Evaluation of prostate-specific antigen and total serum acid phosphatase in prostatic carcinoma. National Journal of Physiology, Pharmacy and Pharmacology, 13 (5), 1065-1071. doi:10.5455/njppp.2023.13.03140202304042023